These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 22676843)

  • 1. Converging prescription brand shares as evidence of physician learning.
    Walker D
    Health Mark Q; 2012; 29(2):163-79. PubMed ID: 22676843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Policy versus practice: comparison of prescribing therapy and durable medical equipment in medical and educational settings.
    Sneed RC; May WL; Stencel C
    Pediatrics; 2004 Nov; 114(5):e612-25. PubMed ID: 15520092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Asymmetric responsiveness of physician prescription behavior to drug promotion of competitive brands within an established therapeutic drug class.
    Pedan A; Wu H
    Health Mark Q; 2011 Apr; 28(2):133-54. PubMed ID: 21590561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are pharmaceutical marketing decisions calibrated to communications effects?
    Cavusgil E; Calantone R
    Health Mark Q; 2011 Oct; 28(4):317-36. PubMed ID: 22054028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physician acquiescence to patient demands for brand-name drugs: results of a national survey of physicians.
    Campbell EG; Pham-Kanter G; Vogeli C; Iezzoni LI
    JAMA Intern Med; 2013 Feb; 173(3):237-9. PubMed ID: 23303297
    [No Abstract]   [Full Text] [Related]  

  • 6. Physicians, the industry and population health.
    Gérvas J; Mansfield PR
    J Epidemiol Community Health; 2009 Oct; 63(10):773-4. PubMed ID: 19749125
    [No Abstract]   [Full Text] [Related]  

  • 7. The death of common sense.
    Trachtman H
    Am J Bioeth; 2003; 3(3):W31-W32. PubMed ID: 14594484
    [No Abstract]   [Full Text] [Related]  

  • 8. Who are the opinion leaders? The physicians, pharmacists, patients, and direct-to-consumer prescription drug advertising.
    Lee AL
    J Health Commun; 2010 Sep; 15(6):629-55. PubMed ID: 20812124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct-to-consumer advertising of prescription drugs: balancing benefits and risks, and a way forward.
    Kravitz RL; Bell RA
    Clin Pharmacol Ther; 2007 Oct; 82(4):360-2. PubMed ID: 17851573
    [No Abstract]   [Full Text] [Related]  

  • 10. An assessment of direct-to-consumer advertising of prescription drugs.
    Calfee JE
    Clin Pharmacol Ther; 2007 Oct; 82(4):357-60. PubMed ID: 17851572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lunch with Lilly: who pays?
    Strong C
    Am J Bioeth; 2003; 3(3):62-3. PubMed ID: 14594499
    [No Abstract]   [Full Text] [Related]  

  • 12. The high cost of free lunch.
    Wall LL; Brown D
    Obstet Gynecol; 2007 Jul; 110(1):169-73. PubMed ID: 17601912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Financial incentives and physicians' prescription decisions on the choice between brand-name and generic drugs: evidence from Taiwan.
    Liu YM; Yang YH; Hsieh CR
    J Health Econ; 2009 Mar; 28(2):341-9. PubMed ID: 19091433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physician use of brand versus generic drug names in 1993-1994 and 2003-2004.
    Kwo EC; Kamat P; Steinman MA
    Ann Pharmacother; 2009 Mar; 43(3):459-68. PubMed ID: 19261956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physician switching after drug request refusal.
    Lee D; Begley CE
    Health Mark Q; 2011 Oct; 28(4):304-16. PubMed ID: 22054027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Doctors who take company cash are more likely to prescribe brand name drugs, analysis finds.
    McCarthy M
    BMJ; 2016 Mar; 352():i1645. PubMed ID: 27000964
    [No Abstract]   [Full Text] [Related]  

  • 17. Doctors don't fall for the hard sell.
    Randerson J
    New Sci; 2003 Jun; 178(2401):10. PubMed ID: 14686412
    [No Abstract]   [Full Text] [Related]  

  • 18. Determinants of generic entry in the regulated Taiwanese prescription drug market.
    Liu YM; Cheng JS
    Health Policy; 2012 Dec; 108(2-3):228-35. PubMed ID: 23020970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The origin of informed consent].
    Mallardi V
    Acta Otorhinolaryngol Ital; 2005 Oct; 25(5):312-27. PubMed ID: 16602332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmaceutical industry influences on physician prescribing: gifts, quasi-gifts, and patient-directed gifts.
    Berger JT
    Am J Bioeth; 2003; 3(3):56-7. PubMed ID: 14594495
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.